Page 69 - @林口醫研部201909電子報
P. 69

FAM129B,  an antioxidative protein,  reduces
                                         chemosensitivity by competing with Nrf2 for Keap1
                                         binding.
                                         IF=6.68 (領域百分⽐:8.09%)

                                         EBIOMEDICINE, 2019 Jul.
                                         指導作者:幹細胞與轉譯癌症研究所 陳鈴津教授







                                         Utilization of optically induced dielectrophoresis in a
                                         microfluidic system for sorting and isolation of cells
                                         with varied degree of viability: Demonstration of the
                                         sorting and isolation of drug-treated cancer cells
                                         with various degrees of anti-cancer drug resistance
                                         gene expression.
                                         IF=6.393 (領域百分⽐:3.28%)

                                         SENSORS AND ACTUATORS B-CHEMICAL, 2019 Mar.
                                         第⼀作者:⾎液腫瘤科 謝佳訓醫師





                                         The Prognostic Roles of Pretreatment Circulating
                                         Tumor Cells,  Circulating Cancer Stem-Like Cells,  and
                                         Programmed Cell Death-1 Expression on Peripheral
                                         Lymphocytes in Patients with Initially Unresectable,
                                         Recurrent or Metastatic Head and Neck Cancer: An
                                         Exploratory Study of Three Biomarkers in One-time
                                         Blood Drawing.
                                         IF= 6.162 (領域百分⽐:13.54 %)

                                         CANCERS, 2019 Apr.

                                         指導作者:⾎液腫瘤科 謝佳訓醫師






                                         Polymorphisms of Mismatch Repair Pathway Genes
                                         Predict Clinical Outcomes in Oral Squamous Cell
                                         Carcinoma Patients Receiving Adjuvant Concurrent

                                         Chemoradiotherapy.
                                         IF= 6.162 (領域百分⽐:13.54 %)

                                         CANCERS, 2019 may.
                                         指導作者:⽿鼻喉科 ⿈祥富醫師






          Department of Medical Research & Development,  Linkou Newsletter                                             69
   64   65   66   67   68   69   70   71   72   73   74